Cogent Biosciences, Inc. – NASDAQ:COGT
Cogent Biosciences stock price today
$11.76
+4.02
+51.94%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Cogent Biosciences stock price monthly change
-16.50%
month
Cogent Biosciences stock price quarterly change
-16.50%
quarter
Cogent Biosciences stock price yearly change
+31.86%
year
Cogent Biosciences key metrics
Market Cap | 842.82M |
Enterprise value | 616.37M |
P/E | -4.34 |
EV/Sales | N/A |
EV/EBITDA | -4.72 |
Price/Sales | N/A |
Price/Book | 2.88 |
PEG ratio | 0.09 |
EPS | -2.48 |
Revenue | N/A |
EBITDA | -225.43M |
Income | -212.17M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCogent Biosciences stock price history
Cogent Biosciences stock forecast
Cogent Biosciences financial statements
| Jun 2023 | 0 | -44.07M | |
|---|---|---|---|
| Sep 2023 | 0 | -55.38M | |
| Dec 2023 | 5.58M | -54.36M | -972.89% |
| Mar 2024 | 0 | -58.34M |
| Mar 2024 | 0 | -58.34M | |
|---|---|---|---|
| Sep 2025 | 1.1M | -31.22M | -2838.45% |
| Oct 2025 | 1.08M | -46.14M | -4249.4% |
| Dec 2025 | 1.67M | -46.98M | -2798.24% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 392369000 | 43.94M | 11.2% |
|---|---|---|---|
| Sep 2023 | 355446000 | 52.54M | 14.78% |
| Dec 2023 | 313437000 | 55.63M | 17.75% |
| Mar 2024 | 476111000 | 53.77M | 11.3% |
| Jun 2023 | -32.06M | -77.66M | 162.09M |
|---|---|---|---|
| Sep 2023 | -37.97M | -90.53M | 1M |
| Dec 2023 | -44.07M | 10.48M | 0 |
| Mar 2024 | -52.52M | 1.04M | 214.05M |
Cogent Biosciences alternative data
| Aug 2023 | 138 |
|---|---|
| Sep 2023 | 138 |
| Oct 2023 | 138 |
| Nov 2023 | 138 |
| Dec 2023 | 138 |
| Jan 2024 | 138 |
| Feb 2024 | 138 |
| Mar 2024 | 164 |
| Apr 2024 | 164 |
| May 2024 | 164 |
| Jun 2024 | 164 |
| Jul 2024 | 164 |
Cogent Biosciences other data
25.22%
-74.78%
of COGT is owned by hedge funds
67
-66
14.81M
-60.05M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2023 | 800000 | 0 |
| Insider | Compensation |
|---|---|
| Dr. Jessica Sachs M.D. (1975) Chief Medical Officer | $1,070,000 |
Mr. John L. Green C.A., CPA (1980) Chief Financial Officer & Principal Accounting Officer | $763,990 |
Mr. Andrew R. Robbins M.B.A. (1976) Pres, Chief Executive Officer & Director | $166,950 |
3 Biotech Stocks With Notable Insider Buying
Cogent Biosciences: Buy The Pullback For Bezuclastinib's 2025 SM And GIST Data
Cogent Biosciences Is Beginning To Differentiate Its KIT Inhibitor
Cogent Biosciences: APEX Part 2 Launched, ErbB2 And FGFR2 On Track
Cogent Biosciences: Bezuclastinib's Potential In Treating Gastrointestinal Stromal Tumors
Cogent Biosciences: Multiple Inflection Points For FY23, Hold For Now
Cogent Biosciences: What's Ahead
-
What's the price of Cogent Biosciences stock today?
One share of Cogent Biosciences stock can currently be purchased for approximately $11.76.
-
When is Cogent Biosciences's next earnings date?
Unfortunately, Cogent Biosciences's (COGT) next earnings date is currently unknown.
-
Does Cogent Biosciences pay dividends?
No, Cogent Biosciences does not pay dividends.
-
How much money does Cogent Biosciences make?
Cogent Biosciences has a market capitalization of 842.82M.
-
What is Cogent Biosciences's stock symbol?
Cogent Biosciences, Inc. is traded on the NASDAQ under the ticker symbol "COGT".
-
What is Cogent Biosciences's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Cogent Biosciences?
Shares of Cogent Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Cogent Biosciences's key executives?
Cogent Biosciences's management team includes the following people:
- Dr. Jessica Sachs M.D. Chief Medical Officer(age: 50, pay: $1,070,000)
- Mr. John L. Green C.A., CPA Chief Financial Officer & Principal Accounting Officer(age: 45, pay: $763,990)
- Mr. Andrew R. Robbins M.B.A. Pres, Chief Executive Officer & Director(age: 49, pay: $166,950)
-
How many employees does Cogent Biosciences have?
As Jul 2024, Cogent Biosciences employs 164 workers.
-
When Cogent Biosciences went public?
Cogent Biosciences, Inc. is publicly traded company for more then 7 years since IPO on 29 Mar 2018.
-
What is Cogent Biosciences's official website?
The official website for Cogent Biosciences is cogentbio.com.
-
Where are Cogent Biosciences's headquarters?
Cogent Biosciences is headquartered at 200 Cambridge Park Drive, Cambridge, MA.
-
How can i contact Cogent Biosciences?
Cogent Biosciences's mailing address is 200 Cambridge Park Drive, Cambridge, MA and company can be reached via phone at +61 79455576.
Cogent Biosciences company profile:
Cogent Biosciences, Inc.
cogentbio.comExchange:
NASDAQ
Full time employees:
164
Industry:
Biotechnology
Sector:
Healthcare
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
200 Cambridge Park Drive
Cambridge, MA 02140
Cambridge, MA 02140
CIK: 0001622229
ISIN: US19240Q2012
CUSIP: 19240Q201
